BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28735365)

  • 21. Immunotherapy for lymphomas.
    Timmerman JM
    Int J Hematol; 2003 Jun; 77(5):444-55. PubMed ID: 12841382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.
    Brower V
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838441
    [No Abstract]   [Full Text] [Related]  

  • 23. Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
    Vose JM
    Hematol Oncol; 2006 Jun; 24(2):47-55. PubMed ID: 16447298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for anti-CD137 cancer immunotherapy.
    Makkouk A; Chester C; Kohrt HE
    Eur J Cancer; 2016 Feb; 54():112-119. PubMed ID: 26751393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of mechanism-based targeted therapies for malignant lymphoma].
    Rai S
    Rinsho Ketsueki; 2020; 61(9):1266-1274. PubMed ID: 33162525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
    Podar K; Jager D
    Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
    Kebriaei P; Poon ML
    Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches in cancer immunotherapy.
    Subramaniam DS; Liu SV; Giaccone G
    Discov Med; 2016 Apr; 21(116):267-74. PubMed ID: 27232512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model.
    Panjideh H; Müller G; Koch M; Wilde F; Scheu S; Moldenhauer G; Lipp M
    Int J Cancer; 2014 Dec; 135(11):2623-32. PubMed ID: 24729415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy in aggressive B-cell lymphomas.
    Jacobson CA; Armand P
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):299-305. PubMed ID: 30213400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.
    Suzuki M; Curran KJ; Cheung NK
    Pediatr Blood Cancer; 2015 Aug; 62(8):1326-36. PubMed ID: 25832831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The progress and current status of immunotherapy in acute myeloid leukemia.
    Yang D; Zhang X; Zhang X; Xu Y
    Ann Hematol; 2017 Dec; 96(12):1965-1982. PubMed ID: 29080982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of patients with malignant lymphomas with monoclonal antibodies.
    Tesch H; Engert A; Manzke O; Diehl V; Bohlen H
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S50-3. PubMed ID: 10933189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic vaccine for lymphoma.
    Lee ST; Neelapu SS; Kwak LW
    Yonsei Med J; 2007 Feb; 48(1):1-10. PubMed ID: 17326239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions.
    Klinger M; Benjamin J; Kischel R; Stienen S; Zugmaier G
    Immunol Rev; 2016 Mar; 270(1):193-208. PubMed ID: 26864113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancer immunotherapy: Rational and recent breakthroughs].
    Granier C; Karaki S; Roussel H; Badoual C; Tran T; Anson M; Fabre E; Oudard S; Tartour E
    Rev Med Interne; 2016 Oct; 37(10):694-700. PubMed ID: 27370898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.
    Barth MJ; Chu Y; Hanley PJ; Cairo MS
    Br J Haematol; 2016 May; 173(4):597-616. PubMed ID: 27062282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current therapeutic strategies for mantle cell lymphoma].
    Dreyling M; Schnaiter A; Schmidt C; Hoster E
    Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New antibody approaches to lymphoma therapy.
    Suresh T; Lee LX; Joshi J; Barta SK
    J Hematol Oncol; 2014 Sep; 7():58. PubMed ID: 25355407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.